Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2021 2
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
Vanni T, Thomé BC, Sparrow E, Friede M, Fox CB, Beckmann AM, Huynh C, Mondini G, Silveira DH, Viscondi JYK, Braga PE, Silva AD, Salomão MDG, Piorelli RO, Santos JP, Gattás VL, Lucchesi MBB, Oliveira MMM, Koike ME, Kallas EG, Campos LMA, Coelho EB, Siqueira MAM, Garcia CC, Miranda MD, Paiva TM, Timenetsky MDCST, Adami EA, Akamatsu MA, Ho PL, Precioso AR. Vanni T, et al. Among authors: miranda md. PLoS One. 2022 Oct 18;17(10):e0274943. doi: 10.1371/journal.pone.0274943. eCollection 2022. PLoS One. 2022. PMID: 36256646 Free PMC article. Clinical Trial.
Antiviral Effect of 5'-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection.
Tucci AR, da Rosa RM, Rosa AS, Augusto Chaves O, Ferreira VNS, Oliveira TKF, Coutinho Souza DD, Borba NRR, Dornelles L, Rocha NS, Mayer JCP, da Rocha JBT, Rodrigues OED, Miranda MD. Tucci AR, et al. Among authors: miranda md. Molecules. 2023 Sep 19;28(18):6696. doi: 10.3390/molecules28186696. Molecules. 2023. PMID: 37764472 Free PMC article.
SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System.
Barreto-Vieira DF, da Silva MAN, de Almeida ALT, Rasinhas ADC, Monteiro ME, Miranda MD, Motta FC, Siqueira MM, Girard-Dias W, Archanjo BS, Bozza PT, L Souza TM, Gomes Dias SS, Soares VC, Barth OM. Barreto-Vieira DF, et al. Among authors: miranda md. Viruses. 2022 Jan 20;14(2):201. doi: 10.3390/v14020201. Viruses. 2022. PMID: 35215794 Free PMC article.
Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
Barreto-Vieira DF, da Silva MAN, Garcia CC, Miranda MD, Matos ADR, Caetano BC, Resende PC, Motta FC, Siqueira MM, Girard-Dias W, Archanjo BS, Barth OM. Barreto-Vieira DF, et al. Among authors: miranda md. Mem Inst Oswaldo Cruz. 2021 Feb 8;116:e200443. doi: 10.1590/0074-02760200443. eCollection 2021. Mem Inst Oswaldo Cruz. 2021. PMID: 33566951 Free PMC article.
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
Sacramento CQ, Fintelman-Rodrigues N, Dias SSG, Temerozo JR, Da Silva APD, da Silva CS, Blanco C, Ferreira AC, Mattos M, Soares VC, Pereira-Dutra F, Miranda MD, Barreto-Vieira DF, da Silva MAN, Santos SS, Torres M, Chaves OA, Rajoli RKR, Paccanaro A, Owen A, Bou-Habib DC, Bozza PT, Souza TML. Sacramento CQ, et al. Among authors: miranda md. Viruses. 2022 Feb 11;14(2):374. doi: 10.3390/v14020374. Viruses. 2022. PMID: 35215969 Free PMC article.
Inactivation of SARS-CoV-2 by a chitosan/α-Ag2WO4 composite generated by femtosecond laser irradiation.
Pereira PFS, de Paula E Silva ACA, da Silva Pimentel BNA, Pinatti IM, Simões AZ, Vergani CE, Barreto-Vieira DF, da Silva MAN, Miranda MD, Monteiro MES, Tucci A, Doñate-Buendía C, Mínguez-Vega G, Andrés J, Longo E. Pereira PFS, et al. Among authors: miranda md. Sci Rep. 2022 May 17;12(1):8118. doi: 10.1038/s41598-022-11902-5. Sci Rep. 2022. PMID: 35581241 Free PMC article.
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro.
Saramago LC, Santana MV, Gomes BF, Dantas RF, Senger MR, Oliveira Borges PH, Ferreira VNDS, Dos Santos Rosa A, Tucci AR, Dias Miranda M, Lukacik P, Strain-Damerell C, Owen CD, Walsh MA, Ferreira SB, Silva-Junior FP. Saramago LC, et al. Among authors: dias miranda m. J Chem Inf Model. 2023 May 8;63(9):2866-2880. doi: 10.1021/acs.jcim.3c00409. Epub 2023 Apr 14. J Chem Inf Model. 2023. PMID: 37058135
Low prevalence of influenza A strains with resistance markers in Brazil during 2017-2019 seasons.
Sousa TDC, Martins JSCC, Miranda MD, Garcia CC, Resende PC, Santos CA, Debur MDC, Rodrigues RR, Cavalcanti AC, Gregianini TS, Iani FCM, Pereira FM, Fernandes SB, Ferreira JA, Santos KCO, Motta F, Brown D, de Almeida WAF, Siqueira MM, Matos ADR. Sousa TDC, et al. Among authors: miranda md. Front Public Health. 2022 Sep 14;10:944277. doi: 10.3389/fpubh.2022.944277. eCollection 2022. Front Public Health. 2022. PMID: 36187691 Free PMC article.
Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication.
Leal CM, Leitão SG, Sausset R, Mendonça SC, Nascimento PHA, de Araujo R Cheohen CF, Esteves MEA, Leal da Silva M, Gondim TS, Monteiro MES, Tucci AR, Fintelman-Rodrigues N, Siqueira MM, Miranda MD, Costa FN, Simas RC, Leitão GG. Leal CM, et al. Among authors: miranda md. Rev Bras Farmacogn. 2021;31(5):658-666. doi: 10.1007/s43450-021-00162-5. Epub 2021 Jul 20. Rev Bras Farmacogn. 2021. PMID: 34305198 Free PMC article.
15 results